Maker of Wegovy Limits Supply of Obesity Drug in U.S.
FRIDAY, May 5, 2023 (HealthDay News) – Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply. The medication is one of three drugs from a classContinue Reading